Polypharmacy as New Risk Factor of Major Bleeding in Patients Undergoing Coronary Stent Implantation　― Which Come First, the Chicken or the Egg? ―

Polypharmacy and Bleeding Outcomes After Percutaneous Coronary Intervention

(2023) Ko Yamamoto et al.   CIRCULATION JOURNAL

Thrombocytopenia as a Bleeding Risk Factor in Atrial Fibrillation and Coronary Artery Disease: Insights From the AFIRE Study

(2023) Raisuke Iijima et al.   Journal of the American Heart Association

JCS 2022 Guideline Focused Update on Diagnosis and Treatment in Patients With Stable Coronary Artery Disease

(2022) Shintaro Nakano et al.   CIRCULATION JOURNAL

Antiplatelet therapy after percutaneous coronary intervention: current status and future perspectives

(2022) Masahiro Natsuaki et al.   Cardiovascular Intervention and Therapeutics

Effect of Polypharmacy on Clinical Outcomes in Elderly Patients With Non-Valvular Atrial Fibrillation　― A Sub-Analysis of the ANAFIE Registry ―

(2022) Takeshi Yamashita et al.   CIRCULATION JOURNAL

Prevalence and factors associated with polypharmacy: a systematic review and Meta-analysis

(2022) Mahin Delara et al.   BMC Geriatrics

Polypharmacy in Elderly Patients With Non-Valvular Atrial Fibrillation　― The Trail to Adverse Events ―

(2022) Masahide Harada   CIRCULATION JOURNAL

Polypill Strategy in Secondary Cardiovascular Prevention

(2022) Jose M. Castellano et al.   NEW ENGLAND JOURNAL OF MEDICINE

JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure

(2021) Hiroyuki Tsutsui et al.   CIRCULATION JOURNAL